CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,746,000 | +422.5% | 72,519 | +150.9% | 0.00% | +300.0% |
| Q2 2022 | $717,000 | +43.1% | 28,908 | +44.5% | 0.00% | – |
| Q1 2022 | $501,000 | -46.9% | 20,000 | -22.8% | 0.00% | -100.0% |
| Q4 2021 | $943,000 | -16.3% | 25,900 | -60.7% | 0.00% | 0.0% |
| Q3 2021 | $1,126,000 | -77.9% | 65,826 | -82.7% | 0.00% | -75.0% |
| Q2 2021 | $5,101,000 | -56.2% | 380,911 | +67.6% | 0.00% | -63.6% |
| Q1 2021 | $11,645,000 | -73.0% | 227,273 | -67.4% | 0.01% | -71.8% |
| Q4 2020 | $43,164,000 | +1.8% | 697,094 | -9.9% | 0.04% | -9.3% |
| Q3 2020 | $42,386,000 | +501.1% | 773,470 | +531.1% | 0.04% | +437.5% |
| Q2 2020 | $7,051,000 | +694.9% | 122,550 | +455.3% | 0.01% | +700.0% |
| Q1 2020 | $887,000 | -34.0% | 22,068 | -35.0% | 0.00% | -50.0% |
| Q4 2019 | $1,344,000 | +270.2% | 33,971 | -36.4% | 0.00% | – |
| Q3 2019 | $363,000 | -58.1% | 53,417 | -42.7% | 0.00% | -100.0% |
| Q2 2019 | $867,000 | -50.6% | 93,210 | -26.2% | 0.00% | -50.0% |
| Q1 2019 | $1,756,000 | -25.1% | 126,359 | -41.2% | 0.00% | -33.3% |
| Q4 2018 | $2,344,000 | -28.6% | 214,899 | -17.3% | 0.00% | -25.0% |
| Q3 2018 | $3,285,000 | -9.8% | 259,837 | -6.0% | 0.00% | -20.0% |
| Q2 2018 | $3,641,000 | -24.1% | 276,454 | -21.7% | 0.01% | -28.6% |
| Q1 2018 | $4,799,000 | +212.6% | 352,867 | +36.8% | 0.01% | +250.0% |
| Q4 2017 | $1,535,000 | -15.8% | 257,978 | +5.0% | 0.00% | -33.3% |
| Q3 2017 | $1,823,000 | -19.4% | 245,635 | +1.7% | 0.00% | -25.0% |
| Q2 2017 | $2,262,000 | +17.8% | 241,564 | -8.4% | 0.00% | +33.3% |
| Q1 2017 | $1,920,000 | -24.4% | 263,821 | -23.2% | 0.00% | -25.0% |
| Q4 2016 | $2,541,000 | +130.8% | 343,425 | +88.4% | 0.00% | +100.0% |
| Q3 2016 | $1,101,000 | +26.4% | 182,287 | -6.0% | 0.00% | 0.0% |
| Q2 2016 | $871,000 | +47.1% | 193,989 | -18.4% | 0.00% | +100.0% |
| Q1 2016 | $592,000 | -60.9% | 237,779 | +27.2% | 0.00% | -50.0% |
| Q4 2015 | $1,514,000 | +77.1% | 186,886 | +32.3% | 0.00% | +100.0% |
| Q3 2015 | $855,000 | -38.6% | 141,289 | -16.5% | 0.00% | -50.0% |
| Q2 2015 | $1,392,000 | +64.9% | 169,195 | +51.4% | 0.00% | +100.0% |
| Q1 2015 | $844,000 | +22.1% | 111,770 | +10.5% | 0.00% | 0.0% |
| Q4 2014 | $691,000 | +471.1% | 101,158 | +277.5% | 0.00% | – |
| Q3 2014 | $121,000 | +42.4% | 26,799 | +84.8% | 0.00% | – |
| Q2 2014 | $85,000 | -76.0% | 14,501 | -77.2% | 0.00% | -100.0% |
| Q3 2013 | $354,000 | -70.9% | 63,702 | -26.1% | 0.00% | -50.0% |
| Q2 2013 | $1,218,000 | – | 86,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |